The fact that this study showed a significant difference in its primary end point and the objective response rate suggests that FOLFIRINOX should be considered as a standard of care,” researchers ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.